Loading clinical trials...
Loading clinical trials...
The primary goal of this Phase 2 clinical trial is to determine the effects of a novel V1a receptor antagonist (NTX-1472) in adults with Social Anxiety Disorder (SAD). The main questions this trial ai...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Newleos Therapeutics, Inc.
NCT07456631 · Social Anxiety Disorder (SAD), Oppositional Defiant Disorder
NCT07325929 · Social Anxiety Disorder (SAD)
NCT00231348 · Social Anxiety Disorder (SAD)
SOAR Clinical Study Site
Pheonix, Arizona
SOAR Clinical Study Site
Encino, California
SOAR Clinical Study Site
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions